These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31324811)

  • 41. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.
    Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z
    Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paclitaxel-Paclitaxel Prodrug Nanoassembly as a Versatile Nanoplatform for Combinational Cancer Therapy.
    Han X; Chen J; Jiang M; Zhang N; Na K; Luo C; Zhang R; Sun M; Lin G; Zhang R; Ma Y; Liu D; Wang Y
    ACS Appl Mater Interfaces; 2016 Dec; 8(49):33506-33513. PubMed ID: 27960378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Self-Assembly of pH-Labile Polymer Nanoparticles for Paclitaxel Prodrug Delivery: Formulation, Characterization, and Evaluation.
    Levit SL; Gade NR; Roper TD; Yang H; Tang C
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rational Design of Redox-Responsive and P-gp-Inhibitory Lipid Nanoparticles with High Entrapment of Paclitaxel for Tumor Therapy.
    Chen SQ; Wang C; Tao S; Wang YX; Hu FQ; Yuan H
    Adv Healthc Mater; 2018 Sep; 7(17):e1800485. PubMed ID: 29995353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
    Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
    [No Abstract]   [Full Text] [Related]  

  • 46. Dual-Prodrug-Based Hyaluronic Acid Nanoplatform Provides Cascade-Boosted Drug Delivery for Oxidative Stress-Enhanced Chemotherapy.
    Zhang J; Deng M; Xu C; Li D; Yan X; Gu Y; Zhong M; Gao H; Liu Y; Zhang J; Qu X; Zhang J
    ACS Appl Mater Interfaces; 2024 Sep; 16(38):50459-50473. PubMed ID: 39258403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrating a novel SN38 prodrug into the PEGylated liposomal system as a robust platform for efficient cancer therapy in solid tumors.
    Fang T; Dong Y; Zhang X; Xie K; Lin L; Wang H
    Int J Pharm; 2016 Oct; 512(1):39-48. PubMed ID: 27544846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy.
    Li Y; Chen M; Yao B; Lu X; Zhang X; He P; Vasilatos SN; Ren X; Bian W; Yao C
    J Mater Chem B; 2019 Oct; 7(38):5814-5824. PubMed ID: 31495855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluorinated paclitaxel prodrugs for potentiated stability and chemotherapy.
    Jiang B; Hao D; Li C; Lu S; Pei Q; Xie Z
    J Mater Chem B; 2021 Dec; 9(48):9971-9979. PubMed ID: 34871339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.
    Han J; Michel AR; Lee HS; Kalscheuer S; Wohl A; Hoye TR; McCormick AV; Panyam J; Macosko CW
    Mol Pharm; 2015 Dec; 12(12):4329-35. PubMed ID: 26505116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Programmed Hydrolysis in Designing Paclitaxel Prodrug for Nanocarrier Assembly.
    Fu Q; Wang Y; Ma Y; Zhang D; Fallon JK; Yang X; Liu D; He Z; Liu F
    Sci Rep; 2015 Jul; 5():12023. PubMed ID: 26166066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The length of disulfide bond-containing linkages impacts the oral absorption and antitumor activity of paclitaxel prodrug-loaded nanoemulsions.
    Gao Y; Zuo S; Li L; Liu T; Dong F; Wang X; Zhang X; He Z; Zhai Y; Sun B; Sun J
    Nanoscale; 2021 Jun; 13(23):10536-10543. PubMed ID: 34100041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Docetaxel prodrug self-assembled nanosystem: Synthesis, formulation and cytotoxicity.
    Jing F; Guo Q; Xu W; Qu H; Sui Z
    Bioorg Med Chem Lett; 2018 Feb; 28(4):826-830. PubMed ID: 29395972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Revealing the impact of modified modules flexibility on gemcitabine prodrug nanoassemblies for effective cancer therapy.
    Guo J; Zhang X; Dong F; Wang S; Wang D; Li Y; Zuo S; Wang Q; Li W; Sun J; He Z; Zhang T; Jiang Q; Sun B
    J Colloid Interface Sci; 2025 Jan; 677(Pt A):941-952. PubMed ID: 39128288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pulmonary Delivery of Reactive Oxygen Species/Glutathione-Responsive Paclitaxel Dimeric Nanoparticles Improved Therapeutic Indices against Metastatic Lung Cancer.
    Tian X; Bera H; Guo X; Xu R; Sun J; He Z; Cun D; Yang M
    ACS Appl Mater Interfaces; 2021 Dec; 13(48):56858-56872. PubMed ID: 34806372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
    Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
    J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Co-delivery of paclitaxel and doxorubicin using mixed micelles based on the redox sensitive prodrugs.
    Yang M; Ding H; Zhu Y; Ge Y; Li L
    Colloids Surf B Biointerfaces; 2019 Mar; 175():126-135. PubMed ID: 30529818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing.
    Ao M; Yu F; Li Y; Zhong M; Tang Y; Yang H; Wu X; Zhuang Y; Wang H; Sun X; Hong X; Chen XD
    J Nanobiotechnology; 2021 Oct; 19(1):350. PubMed ID: 34717646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy.
    He X; Cai K; Zhang Y; Lu Y; Guo Q; Zhang Y; Liu L; Ruan C; Chen Q; Chen X; Li C; Sun T; Cheng J; Jiang C
    ACS Appl Mater Interfaces; 2018 Nov; 10(46):39455-39467. PubMed ID: 30362704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.